Referencias Bibliográficas
Aqui puedes encontrar literatura relacionada con la diabetes, la gran mayoria esta en español, tambien hay material en otros idiomas.Marifé Munoz Grimaldo, Mercedes Galindo Rubio y colaboradores. La enfermera de Primaria y la Diabetes. Guía de la RedGDPS. Edicion V. Laboratorios Bayer (2012)
María Bosch, Teresa Cabasés, Juan José Cabré, Concepció Coma. Manual de educación terapéutica en diabetes. Ediciones Díaz de Santos, S.A. (2011) Daniel Figuerola (editor)
Serafín Murillo. La alimentación de tus niños con diabetes. Nutrición saludable de la infancia a la adolescencia. Editado por: Fundación para la Diabetes, con la colaboración de la Agencia Española de Seguridad Alimentaria (Ministerio de Sanidad y Consumo) y el apoyo de DKV. Madrid, 2008.
Federación de Diabéticos Españoles (FEDE) Tengo Diabetes Tipo 2, ¿qué puedo hacer?
Karlos Arguiñano y Fundación Grande Covián. Controlar la diabetes. Bainet Editorial Volumen 2
Dr. Felipe-E. Juanas Fernández. Consejos de Salud en Diabetes. Diputación Provincial de Ciudad Real, 2005
American Diabetes Association. Report of the Expert Committe on the Diagnosis and Clasification of diabetes Mellitus. Diabetes Care 1997; 20:1187 - 1197.
Asociación Latinoamericana de Diabetes. Consenso sobre Prevención, control y Tratamiento de la Diabetes Mellitus No Insulinodependiente Bs. As., Ediciones Mayo 1995.
Durruty P, Carrasco E, García M y López G. Hemoglobina glucosilada y secreción insulínica en obesos con intolerancia a la glucosa. Rev. Med. Chile 1998; 116:993-997.
Foster D. Diabetes Mellitus. En Isselbacher K, Braunwald E, Wilson J y cols. Harrison: Principios de Medicina interna. 13a. DE., Madrid Interamericana Mc. Graw-Hill. 1994: 2281-2305.
Sir. T, López G, Castillo T y cols. Marcadores bioquímicos y métodos de cuantificación de insulinorresistencia en mujeres normales, obesas e hiperandrogénicas. Rev Méd Chile 1997; 125: 977-985.
Skiler J. Glucose control in type 2 diabetes mellitus Ann Intern Med 1997; 127: 837-838.
Turner R, Cull C and Holman R. United Kingdom Prospective Diabetes Study: A 9- year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med 1996:136-145.
Valdivia H. Diagnóstico y control de la diabetes mellitus. Diagnóstico 1998; 37: 74-82
Villena, J. Tratamiento de la diabetes mellitus tipo 2. Diagnóstico 1998; 37:95?110
Irland M. Diabetes Mellitus. En Ewald G y McKenzie C. Manual de Terapéutica Médica Washington University, 9a Ed., Barcelona, Masson-Little Blow S.A. 1996: 519-550.
Olefsky J. Diabetes Sacarina. En Wyngaarden J, Smith L y Bennett J, Cecil:Tratado de Medicina Interna 19a Ed., México, Interamericana Mc.Graw-Hill, 1994: 1503-1525.
Barrett-Connor E, Khaw KT, Yen S. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 1986; 315: 1519-1524
Baulieu EE. Dehydroepiandrosterone (DHEA): A Fountain of Youth- J Clin Endocrinol Metab 1996; 81: 3147-3151.
Parker L. Adrenal Androgens. In DE Groot L. Endocrinology. 3rd Ed., Philadelphia, W.B. De Saunders Company, 1995: 1836-1851.
Herbert J. La era de la dehidroepiandrosterona. The Lancet (Ed. en español) 1995; 27:209-210.
Quiroz G, ed La dehidroepiandrosterona: Un enigma presto a ser revelado. Medicina Contemporánea 1997; 5: 32-35.
Assan. R, Robel P, Baulieu EE Dehydroepian-drosterone (DHEA) for diabetic patients?, Eur J Endocrinol 1996; 135: 37-38.
Beer N, Jakubowicz D, Beer et al. Effects of nitradipine on glucose tolerance and serun insulin and dehydroepiandrosterone sulfate levels in insuli-resistant obese and hypertensive men. J Clin Endocrinol Metab 1993; 76: 178-183.
Davies L, Pryo K, Twigg S et al. Any association between low serum DHEAS levels and ischaemic heart disease in NIDDM is negated by age. 16th international Diabetes Federation Congress Abstracts, Diabetologia Supplement 1997, N° 1730.
Denti L, Pasolini G, Sanfelici L, et al. Effects of aging on dehydroepiandrosterone sulfate in relation to fasting insulin levels and body composition assessed by bioimpedance analysis. Metabolism 1997; 46: 826-832.
Hamano K, Ajima M, Okazaki R. and Totsuka Y. The roles of DHEA and DHEAS in NIDDM patients: A possible modulator of glucose metabolism. 16th International Diabetes Federation Congress Astracts, Diabetologia Supplement 1997; N° 1154.
Herranz L, Megia A, Grande C et al. Dehydroepiandrosterone sulphate, body fat distribution and insulin in obese men. Int J Obes Relat Metab Disord 1995; 19: 57-60
Lavalleé B, Provost P, Khawash Z et al. Effect of insulin or serum levels of dehydroepiandrosterone metabolites in men. Clin Endocrinol Oxf 1997; 46: 93-100.
Loviselli A, Pisanu P, Cossu E et al. Low levels of dehydroepiandrosterone sulfate in adult males with insulindependent diabetes mellitus. Minerva Endocrinol 1994; 19: 113-119.
Nestler J and McClanahan M. Diabetes and adrenal disease. Baillieres Clin Endocrinol Metab 1992; 6: 829-847.
Paolisso G, Ammendola S, Rotondi M et al. Insulin resistance and advancing age: What role for dehydroepiandrosterone sulfate-. Metabolism 1997; 46: 1281-1286.
Slowinska-Sezednicka J, Malczewsk B, Srzednicki M et al. Hyperinsulinaemia and decreased plasma levels of dehydroepiandrosterone sulfate in premenopausal women with coronary disease. J Intern Med
Iizuka T, Miyamoto T, ItoH et al Relationship between DHEA-S and insulin sensitivity in patients with non-insulin dependent diabetes mellitus 16th international Diabetes Federation Congress Abstracts, Diabetologia Suplement 1997, N° 1174
Aronne L. Obesity. Medical Clinics of North America 1998; 82: 161-181.
Bjorntorp P. Obesidad. The Lancet (Ed. en español) 1997; 31: 376-379.
De pergola G, Triggiani V, Giorgino F et al. The Testosterone to dehydroepiandrosterone sulphate molar ratio as a marker of visceral fat accumulation in premenopausal obese women. Int J Obes relat Metab Disord 1994; 18: 659-664.
Farrearas P y Rozman C. Medicina Interna 13a Ed., Mosby/ Doyma Libros, 1995.
Jover E. Indice cintura/cadera. Obesidad y riesgo cardiovascular. An Med Intern (Madrid) 1997; 14: 9- 10.
Maggio C. and Pi-Sunyer F. The prevention and treatment of obesity. Application to type 2 diabetes. Diabetes Care 1997; 20: 1744-1766.
Okamoto K. Yagyu K and Sasaki R. The relationship between serum dehydroepiandrosterone sulfate levels and factors associated with cardiovascular diseases: A cross-sectional study in Japan. Nippon Koshu Eisei Zasshi 1995: 42: 78-83.
Seclén S. Avances en el tratamiento de la diabetes mellitus no insulino dependiente. Diagnóstico 1996; 35:26-33.
Fletcher P, Aguila J y Villanueva J. Valores normales en Panamá de dehidroepiandrosterona sulfato sérico por radioinmunoanálisis. Rev. Méd Caja Seguro Soc 1985; 17: 229-232.
Labrie F, Bélanger A, Cusan L et al. Marked decline in serum concentrations of adrenal C 19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997; 82: 2396-2402.
Sulcová J, Hill M, Hampl R and Stárka L. Age and sex related differences in serum levels of unconjugated dehydroepiandrosterone and its sulphate in normal subjects J Endocrinol 1997; 154:57-62.
Yamauchi A, Takei I, Kasuga A, et al. Depression of dehydroepiandrosterone in Japanese diabetic men - comparison between non-insulin-dependient diabetes mellitus and impaired glucose tolerance. Eur J
Asociación Latinoamericana de Diabetes. Consenso sobre Prevención, control y Tratamiento de la Diabetes Mellitus No Insulinodependiente Bs. As., Ediciones Mayo 1995.
Durruty P, Carrasco E, García M y López G. Hemoglobina glucosilada y secreción insulínica en obesos con intolerancia a la glucosa. Rev. Med. Chile 1998; 116:993-997.
Foster D. Diabetes Mellitus. En Isselbacher K, Braunwald E, Wilson J y cols. Harrison: Principios de Medicina interna. 13a. DE., Madrid Interamericana Mc. Graw-Hill. 1994: 2281-2305.
Sir. T, López G, Castillo T y cols. Marcadores bioquímicos y métodos de cuantificación de insulinorresistencia en mujeres normales, obesas e hiperandrogénicas. Rev Méd Chile 1997; 125: 977-985.
Skiler J. Glucose control in type 2 diabetes mellitus Ann Intern Med 1997; 127: 837-838.
Turner R, Cull C and Holman R. United Kingdom Prospective Diabetes Study: A 9- year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med 1996:136-145.
Valdivia H. Diagnóstico y control de la diabetes mellitus. Diagnóstico 1998; 37: 74-82
Villena, J. Tratamiento de la diabetes mellitus tipo 2. Diagnóstico 1998; 37:95?110
Irland M. Diabetes Mellitus. En Ewald G y McKenzie C. Manual de Terapéutica Médica Washington University, 9a Ed., Barcelona, Masson-Little Blow S.A. 1996: 519-550.
Olefsky J. Diabetes Sacarina. En Wyngaarden J, Smith L y Bennett J, Cecil:Tratado de Medicina Interna 19a Ed., México, Interamericana Mc.Graw-Hill, 1994: 1503-1525.
Barrett-Connor E, Khaw KT, Yen S. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 1986; 315: 1519-1524
Baulieu EE. Dehydroepiandrosterone (DHEA): A Fountain of Youth- J Clin Endocrinol Metab 1996; 81: 3147-3151.
Parker L. Adrenal Androgens. In DE Groot L. Endocrinology. 3rd Ed., Philadelphia, W.B. De Saunders Company, 1995: 1836-1851.
Herbert J. La era de la dehidroepiandrosterona. The Lancet (Ed. en español) 1995; 27:209-210.
Quiroz G, ed La dehidroepiandrosterona: Un enigma presto a ser revelado. Medicina Contemporánea 1997; 5: 32-35.
Assan. R, Robel P, Baulieu EE Dehydroepian-drosterone (DHEA) for diabetic patients?, Eur J Endocrinol 1996; 135: 37-38.
Beer N, Jakubowicz D, Beer et al. Effects of nitradipine on glucose tolerance and serun insulin and dehydroepiandrosterone sulfate levels in insuli-resistant obese and hypertensive men. J Clin Endocrinol Metab 1993; 76: 178-183.
Davies L, Pryo K, Twigg S et al. Any association between low serum DHEAS levels and ischaemic heart disease in NIDDM is negated by age. 16th international Diabetes Federation Congress Abstracts, Diabetologia Supplement 1997, N° 1730.
Denti L, Pasolini G, Sanfelici L, et al. Effects of aging on dehydroepiandrosterone sulfate in relation to fasting insulin levels and body composition assessed by bioimpedance analysis. Metabolism 1997; 46: 826-832.
Hamano K, Ajima M, Okazaki R. and Totsuka Y. The roles of DHEA and DHEAS in NIDDM patients: A possible modulator of glucose metabolism. 16th International Diabetes Federation Congress Astracts, Diabetologia Supplement 1997; N° 1154.
Herranz L, Megia A, Grande C et al. Dehydroepiandrosterone sulphate, body fat distribution and insulin in obese men. Int J Obes Relat Metab Disord 1995; 19: 57-60
Lavalleé B, Provost P, Khawash Z et al. Effect of insulin or serum levels of dehydroepiandrosterone metabolites in men. Clin Endocrinol Oxf 1997; 46: 93-100.
Loviselli A, Pisanu P, Cossu E et al. Low levels of dehydroepiandrosterone sulfate in adult males with insulindependent diabetes mellitus. Minerva Endocrinol 1994; 19: 113-119.
Nestler J and McClanahan M. Diabetes and adrenal disease. Baillieres Clin Endocrinol Metab 1992; 6: 829-847.
Paolisso G, Ammendola S, Rotondi M et al. Insulin resistance and advancing age: What role for dehydroepiandrosterone sulfate-. Metabolism 1997; 46: 1281-1286.
Slowinska-Sezednicka J, Malczewsk B, Srzednicki M et al. Hyperinsulinaemia and decreased plasma levels of dehydroepiandrosterone sulfate in premenopausal women with coronary disease. J Intern Med
1995; 237: 465-472.
Iizuka T, Miyamoto T, ItoH et al Relationship between DHEA-S and insulin sensitivity in patients with non-insulin dependent diabetes mellitus 16th international Diabetes Federation Congress Abstracts, Diabetologia Suplement 1997, N° 1174
Aronne L. Obesity. Medical Clinics of North America 1998; 82: 161-181.
Bjorntorp P. Obesidad. The Lancet (Ed. en español) 1997; 31: 376-379.
De pergola G, Triggiani V, Giorgino F et al. The Testosterone to dehydroepiandrosterone sulphate molar ratio as a marker of visceral fat accumulation in premenopausal obese women. Int J Obes relat Metab Disord 1994; 18: 659-664.
Farrearas P y Rozman C. Medicina Interna 13a Ed., Mosby/ Doyma Libros, 1995.
Jover E. Indice cintura/cadera. Obesidad y riesgo cardiovascular. An Med Intern (Madrid) 1997; 14: 9- 10.
Maggio C. and Pi-Sunyer F. The prevention and treatment of obesity. Application to type 2 diabetes. Diabetes Care 1997; 20: 1744-1766.
Okamoto K. Yagyu K and Sasaki R. The relationship between serum dehydroepiandrosterone sulfate levels and factors associated with cardiovascular diseases: A cross-sectional study in Japan. Nippon Koshu Eisei Zasshi 1995: 42: 78-83.
Seclén S. Avances en el tratamiento de la diabetes mellitus no insulino dependiente. Diagnóstico 1996; 35:26-33.
Fletcher P, Aguila J y Villanueva J. Valores normales en Panamá de dehidroepiandrosterona sulfato sérico por radioinmunoanálisis. Rev. Méd Caja Seguro Soc 1985; 17: 229-232.
Labrie F, Bélanger A, Cusan L et al. Marked decline in serum concentrations of adrenal C 19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997; 82: 2396-2402.
Sulcová J, Hill M, Hampl R and Stárka L. Age and sex related differences in serum levels of unconjugated dehydroepiandrosterone and its sulphate in normal subjects J Endocrinol 1997; 154:57-62.
Yamauchi A, Takei I, Kasuga A, et al. Depression of dehydroepiandrosterone in Japanese diabetic men - comparison between non-insulin-dependient diabetes mellitus and impaired glucose tolerance. Eur J
Endocrinol 1996; 135: 101-104.
